Journal Policies

Digital Archiving & Preservation Policy

ARC Publishing Services L.L.C is committed to ensuring the long-term preservation, integrity, and accessibility of its published scholarly content.

To support this commitment, the International Journal For Research In Biology & Pharmacy (IJRBP) utilizes the PKP Preservation Network (PKP PN), a distributed digital preservation service developed by the Public Knowledge Project (PKP) for journals operating on the Open Journal Systems (OJS) platform. Through PKP PN, published articles and associated metadata are securely archived to support reliable and continued access to the scholarly record.

The PKP Preservation Network preserves journal content across multiple independent and geographically distributed preservation nodes. This distributed archiving model helps protect published content against data loss, technical failures, website disruptions, and other risks that may affect the availability of online journal content. It supports the durability, integrity, and long-term accessibility of research published in the International Journal For Research In Biology & Pharmacy (IJRBP).

Key Features of the Archiving System

  • Long-term digital preservation of all published articles
  • Secure and distributed storage across multiple preservation nodes
  • Protection against data loss, system failures, and platform changes
  • Continued accessibility of content even if the journal website becomes unavailable

This preservation policy reflects the commitment of the International Journal for Research in Biology & Pharmacy and ARC Publishing LLC to internationally recognized practices in scholarly publishing, digital preservation, and research integrity.

Plagiarism and Generative AI Policy

ARC Publishing Services L.L.C is committed to maintaining high standards of publication ethics, originality, academic integrity, and responsible scholarly communication.

All manuscripts submitted to the International Journal For Research in Biology & Pharmacy (IJRBP) are screened using iThenticate plagiarism detection software before peer review and, where necessary, at other stages of the editorial process. Plagiarism in any form—including direct copying, improper paraphrasing, self-plagiarism, data fabrication, falsification, or the unattributed use of text, ideas, data, or figures—is strictly prohibited.

Authors are responsible for ensuring that their submissions are original, appropriately cited, and compliant with applicable copyright and permissions requirements.

The use of Generative AI tools for text generation, paraphrasing, translation, or image creation must be disclosed at the time of submission. AI tools may be used only for language or technical assistance and must not replace human authorship, scholarly interpretation, critical analysis, or academic judgment. Authors remain fully responsible for the accuracy, originality, integrity, and content of their submitted manuscripts. AI-generated content or similarity should not exceed 5% of the manuscript, and AI tools or systems cannot be listed as authors.

Manuscripts that demonstrate unacceptable levels of similarity, undisclosed use of Generative AI, or other ethical concerns may be rejected, returned for correction, or subject to appropriate editorial action, including retraction where necessary, in accordance with the journal's editorial policies and recognized standards of scholarly publishing.

The International Journal For Research in Biology & Pharmacy (IJRBP) and ARC Publishing Services L.L.C support transparency, research integrity, responsible use of technology, and ethical publishing practices.

Open Access Policy

All articles published in the International Journal For Research in Biology & Pharmacy (IJRBP) are freely and permanently accessible online under the journal’s stated open access licensing terms.

Authors retain copyright of their published work while granting ARC Publishing Services L.L.C a non-exclusive license to publish, distribute, and make the article publicly available in accordance with the applicable licensing terms.

Articles are published without an embargo and, where applicable, are assigned Digital Object Identifiers (DOIs) to support persistent citation, identification, and discoverability. Published content is also preserved through secure digital archiving systems to support its long-term accessibility and availability.

In accordance with recognized standards of scholarly publishing, IJRBP maintains transparency regarding open access, copyright ownership, author rights, and licensing conditions. Complete information regarding the applicable license and publication rights is clearly stated on the journal website.

ARC Publishing Services L.L.C is committed to supporting sustainable open access and ensuring that published scholarly content remains accessible to the academic and research community.

Peer Review Policy

All manuscripts submitted to the International Journal For Research in Biology & Pharmacy (IJRBP) undergo an initial editorial assessment to evaluate their relevance to the journal’s scope, originality, formatting requirements, and compliance with ethical and publication standards.

Manuscripts that meet the initial requirements proceed to a double-blind peer review process, in which the identities of both authors and reviewers are kept confidential. Reviews are conducted by independent experts with appropriate academic qualifications and relevant subject-area expertise.

Reviewers evaluate manuscripts based on originality, academic contribution, scientific foundation, methodological rigor, validity of findings, clarity of presentation, and relevance to biology, pharmacy, and related fields.

Based on the reviewers’ recommendations and the overall editorial assessment, the Editorial Team makes the final publication decision. Possible decisions include acceptance, minor revision, major revision, or rejection.

The journal follows ethical peer review practices consistent with internationally recognized standards of scholarly publishing. The review process is conducted with fairness, confidentiality, impartiality, and academic integrity, while maintaining editorial independence throughout the evaluation process.

Post-Publication policy

The International Journal For Research in Biology & Pharmacy (IJRBP) and ARC Publishing Services L.L.C are committed to maintaining the accuracy, reliability, and integrity of the scholarly record.

If errors, ethical concerns, or issues relating to research integrity are identified after an article has been published, the journal will assess the matter and take appropriate action where necessary. Post-publication actions may include:

  • Publication of corrections or errata
  • Issuance of an expression of concern
  • Retraction of an article in cases involving serious ethical concerns, research misconduct, or unreliable or invalid findings

Where appropriate, authors, editors, reviewers, or other relevant parties may be contacted as part of the investigation and resolution process.

All post-publication decisions are made following established editorial procedures and recognized standards of publication ethics. The journal aims to ensure that any necessary corrections, expressions of concern, or retractions are clearly documented and appropriately linked to the original publication to preserve transparency and protect the integrity of the academic record.

IJRBP and ARC Publishing Services L.L.C are committed to responsible post-publication practices and to supporting the long-term reliability and integrity of the scholarly record.